Matt S. Anderson

发表

Structure of HC-toxin, a cyclic tetrapeptide from helminthosporium carbonum

C. Sweeley, D. J. Weber, J. Liesch, 1982 .

Effects of Rifampin, a Potent Inducer of Drug‐Metabolizing Enzymes and an Inhibitor of OATP1B1/3 Transport, on the Single Dose Pharmacokinetics of Anacetrapib

Yang Liu, D. Gutstein, J. Cote, 2013, Journal of clinical pharmacology.

2-(4-carbonylphenyl)benzoxazole inhibitors of CETP: scaffold design and advancement in HDLc-raising efficacy.

S. Wright, S. Eveland, S. A. Hyland, 2011, Bioorganic & medicinal chemistry letters.

A high-precision fluorogenic cholesteryl ester transfer protein assay compatible with animal serum and 3456-well assay technology.

Gregory T O'Donnell, M. Ferrer, B. Strulovici, 2007, Analytical biochemistry.

The Effect of Single and Multiple Doses of Rifampin on the Pharmacokinetics of Doravirine in Healthy Subjects

J. Brejda, J. Butterton, K. Yee, 2017, Clinical Drug Investigation.

Characterisation of the absorption, distribution, metabolism, excretion and mass balance of doravirine, a non-nucleoside reverse transcriptase inhibitor in humans

J. Butterton, K. Yee, Yuexia Liang, 2019, Xenobiotica; the fate of foreign compounds in biological systems.

No Meaningful Drug Interactions with Doravirine, Lamivudine and Tenofovir Disoproxil Fumarate Coadministration

W. Kraft, K. Yee, M. Iwamoto, 2019, Antiviral therapy.

No Pharmacokinetic Drug–Drug Interaction Between Prasugrel and Vorapaxar Following Multiple‐Dose Administration in Healthy Volunteers

D. Cutler, T. Kosoglou, J. Rotonda, 2017, Clinical pharmacology in drug development.

A high-throughput solid-phase extraction assay capable of measuring diverse polyprenyl phosphate: sugar-1-phosphate transferases as exemplified by the WecA, MraY, and MurG proteins.

S. A. Hyland, Matt S. Anderson, 2003, Analytical biochemistry.

A Pharmacokinetic Bioequivalence Study Comparing Sublingual Riluzole (BHV‐0223) and Oral Tablet Formulation of Riluzole in Healthy Volunteers

R. Berman, R. Larouche, V. Coric, 2020, Clinical pharmacology in drug development.

Molecular Cloning oftheGenesforLipid A Disaccharide Synthase andUDP-N-Acetylglucosamine Acyltransferase inEscherichia coli

C. Raetz, D. Crowell, Matt S. Anderson, 1986 .

Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions

L. V. Van Bortel, K. Yee, R. Sanchez, 2019, Antimicrobial Agents and Chemotherapy.

Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women.

Chengcheng Liu, A. Mehta, S. Stoch, 2014, The Journal of clinical endocrinology and metabolism.

P‐Glycoprotein and Breast Cancer Resistance Protein Transporter Inhibition by Cyclosporine and Quinidine on the Pharmacokinetics of Oral Rimegepant in Healthy Subjects

V. Coric, R. Bertz, Jennifer Madonia, 2022, Clinical pharmacology in drug development.

Human Milk and Plasma Pharmacokinetics of Single-Dose Rimegepant 75 mg in Healthy Lactating Women

V. Coric, R. Bertz, Jennifer Madonia, 2022, Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine.

Fluorogenic substrates for high-throughput measurements of endothelial lipase activity Published, JLR Papers in Press, November 7, 2006.

L. Mitnaul, S. Wright, S. T. Waddell, 2007, Journal of Lipid Research.

Safety, Tolerability and Pharmacokinetics of Doravirine, a Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor, after Single and Multiple doses in Healthy Subjects

L. V. Van Bortel, J. Wagner, J. Butterton, 2015, Antiviral therapy.

2-Arylbenzoxazoles as CETP inhibitors: substitution and modification of the alpha-alkoxyamide moiety.

S. Wright, S. Eveland, S. A. Hyland, 2010, Bioorganic & medicinal chemistry letters.

Biphenyl-substituted oxazolidinones as cholesteryl ester transfer protein inhibitors: modifications of the oxazolidinone ring leading to the discovery of anacetrapib.

Amjad Ali, S. Wright, Hong Li, 2011, Journal of medicinal chemistry.

Discovery of substituted biphenyl oxazolidinone inhibitors of cholesteryl ester transfer protein.

Amjad Ali, S. Wright, Zhijian Lu, 2011, ACS medicinal chemistry letters.

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin

S. Engel, T. Musliner, M. Hanson, 2013, Vascular health and risk management.

2-Arylbenzoxazoles as CETP inhibitors: raising HDL-C in cynoCETP transgenic mice.

Amjad Ali, S. Wright, Dooseop Kim, 2011, Bioorganic & medicinal chemistry letters.

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

John A Wagner, Rajesh Krishna, Arthur J Bergman, 2007, The Lancet.

Effect of Raltegravir on the Pharmacokinetics of Methadone

J. Wagner, W. Hanley, M. Iwamoto, 2010, Journal of clinical pharmacology.

2-(4-Carbonylphenyl)benzoxazole inhibitors of CETP: attenuation of hERG binding and improved HDLc-raising efficacy.

S. Eveland, S. A. Hyland, C. Sparrow, 2011, Bioorganic & medicinal chemistry letters.

Field-Based Assessment of the Role of Porcine Cytomegalovirus in Respiratory Disease of Nursery Pigs

J. Zimmerman, K. Yoon, Matt S. Anderson, 1998 .

Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib[S]

R. Krauss, C. Pinto, J. Wagner, 2012, Journal of Lipid Research.

2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety.

Amjad Ali, S. Wright, S. Eveland, 2010, Bioorganic & medicinal chemistry letters.

An ex vivo angiogenesis assay utilizing commercial porcine carotidartery: Modification of the rat aortic ring assay

John M Ronan, J. Boice, A. Fletcher, 2004, Angiogenesis.

Minimal Pharmacokinetic Interaction between the Human Immunodeficiency Virus Nonnucleoside Reverse Transcriptase Inhibitor Etravirine and the Integrase Inhibitor Raltegravir in Healthy Subjects

J. Wagner, J. Stone, T. Kakuda, 2008, Antimicrobial Agents and Chemotherapy.

SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors.

Amjad Ali, S. Wright, Q. Deng, 2012, Bioorganic & medicinal chemistry letters.

Design of a novel class of biphenyl CETP inhibitors.

A. Theberge, Amjad Ali, S. Wright, 2010, Bioorganic & medicinal chemistry letters.

A phase 1 randomized study of hemodynamic effects and pharmacokinetic interactions during concomitant use of rimegepant and sumatriptan in healthy adults

R. Lipton, V. Coric, R. Bertz, 2021, Cephalalgia Reports.

A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir

M. Rizk, J. Butterton, K. Yee, 2017, Clinical Pharmacokinetics.

A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals

J. Wagner, J. Butterton, K. Yee, 2015, AIDS.

The PET tracer [11C]MK-6884 quantifies M4 muscarinic receptor in rhesus monkeys and patients with Alzheimer’s disease

M. Rudd, J. Masdeu, G. Bormans, 2022, Science Translational Medicine.

Effect of raltegravir on estradiol and norgestimate plasma pharmacokinetics following oral contraceptive administration in healthy women.

J. Wagner, J. Stone, W. Hanley, 2011, British journal of clinical pharmacology.

The cell wall and cell division gene cluster in the Mra operon of Pseudomonas aeruginosa: cloning, production, and purification of active enzymes.

M. Anderson, M. El-Sherbeini, Matt S. Anderson, 2001, Protein expression and purification.

First-in-human PET imaging of mGluR2 receptors.

Talakad G. Lohith, G. Bormans, E. Hostetler, 2016 .

Erratum to: A Two-Way Steady-State Pharmacokinetic Interaction Study of Doravirine (MK-1439) and Dolutegravir

M. Rizk, J. Butterton, K. Yee, 2017, Clinical Pharmacokinetics.

Crystal structure of Escherichia coli UDPMurNAc-tripeptide d-alanyl-d-alanine-adding enzyme (MurF) at 2.3 A resolution.

Youwei Yan, S. Munshi, J. Chrzas, 2000, Journal of molecular biology.